R&D
🇺🇸 FDA Page 2FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 13–24 of 117 articles
Sepsis AI algorithms need real-time data, not hindsight
Merck and Gilead report mixed outcomes in lung cancer and HIV studies
Nektar Therapeutics pipeline update: REZPEG, amphotericin B and UK site changes
Sanofi pipeline pdf: Dupixent, Lantus and 2026 catalysts
Cardiff Oncology pipeline update: onvansertib trials, FDA meeting, and catalysts
Neurocrine Biosciences pipeline update: what analysts should watch next
Arcus Biosciences pipeline update: casdatifan, quemliclustat, domvanalimab
Syndax pipeline update: Revuforj and Niktimvo catalysts to watch
$2M Gene Therapy Cures Need a Financing Model
Precision under pressure: logistics facts shaping nuclear medicine scalability
Why innovation alone is no longer enough in biopharma
Novo Nordisk supply of Wegovy stabilizes as new capacity comes online